Profile
Corporate information
Investment activity status
Active investor
Company type
Reseearch venture of the Zambon group.Investments
Investment preferences
Focus industries
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Mission Bay Capital III |
16 Sep 2019 | Fund Closing Active |
|||
SuppreMol GmbH biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases. |
1 May 2006 | Series A Initial investment. Round participant. Active |